Welcome to our dedicated page for OI SA ADR NEW news (Ticker: OIBZQ), a resource for investors and traders seeking the latest updates and insights on OI SA ADR NEW stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect OI SA ADR NEW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of OI SA ADR NEW's position in the market.
Oi S.A. has announced plans to file a Form 15F with the SEC to terminate its registration of all classes of registered securities under the Securities Exchange Act, following the voluntary delisting of its ADRs from the NYSE on October 28, 2021. This filing will suspend its reporting obligations under the Exchange Act and is expected to complete 90 days after submission, barring SEC objections. Oi will retain listings on the São Paulo Stock Exchange under the ticker symbols OIBR3 and OIBR4, continuing to meet local disclosure requirements. The ADRs will remain traded in the U.S. OTC market with symbols OIBZQ and OIBRQ.
FAQ
What is the market cap of OI SA ADR NEW (OIBZQ)?
